Aethlon Medical Chairman to be Interviewed on CNNfn.

Business Editors, Health/Medical Writers

LA JOLLA, Calif.--(BW HealthWire)--May 9, 2001

Pursuant to Regulation FD (Fair Disclosure), Aethlon Medical (OTCBB:AEMD) announced today that the Chairman of the company, Mr. James Joyce, will be interviewed on CNNfn's Business Unusual on Friday, May 11, 2001. The show airs at 8 p.m., 11 p.m. and the following morning at 3 a.m. (EDT) in U.S. cities that carry CNNfn. Mr. Joyce will discuss the company's HIV-Hemopurifier(tm). Due to ever changing circumstances, the interview could be pre-empted, air on a different date, or at an alternate time.

Aethlon Medical is a development stage, therapeutic device company engaged in the discovery and development of novel products that rapidly reduce the presence of viruses and other intoxicants in the blood. Aethlon's lead product candidate, the HIV-Hemopurifier(TM), is designed to fill the urgent need for new HIV/AIDS treatments that are effective in reducing viral load, have fewer side effects and decrease the likelihood of treatment resistance. The Hemopurifier(TM) was recently introduced at the National Blood Safety Conference. Other products in the Aethlon technology portfolio include Hemopurifiers(TM) that treat Hepatitis C, Lead Poisoning, Iron Overload and curb the side effects of certain Chemotherapy.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. (the "Company"), or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers of this press release may obtain additional information on the Company in reports and other information filed in accordance with the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such reports and other information filed by the Company can be inspected and copied at the public reference facilities maintained by the Commission at the Public Reference Room, 450 Fifth Street, N.W., Washington, DC 20549. Copies of such material can also be obtained at prescribed rates from the Public Reference Section of the Commission, Washington, DC 20549 or by calling the Commission at 1-800-SEC-0330. In addition, Registration Statements and other filings made with the Commission through its Electronic Data Gathering Analysis and Retrieval System ("EDGAR") and publicly available through the Commission's website located at http://www.sec.gov.